FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Can the way we talk about cancer change how we interact with the disease?

2.

Long Wait Times on the Other Side of the Pond: King Charles' Cancer Diagnosis.

3.

'Sleep ALL night' program helps children with leukemia sleep better during treatment

4.

Q&A: Researchers discuss identifying potential new protein targets for melanoma therapeutics

5.

MRI can save rectal cancer patients from surgery, study suggests


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot